Takeda Pharmaceutical Co Ltd at Morgan Stanley Healthcare Conference Transcript
Okay. So let's get started with the session with Takeda. First of all, so I need to say for important disclosures, please see the Morgan Stanley research and disclosure website at www.morganstanley.com/researchdisclosures. So yes.
And today, we are with Dr. Andy Plump of -- Head of -- President of R&D of Takeda; and from IR team, Mr. Nobi Azuma-san is here. We need to say that, so -- of course, CFO, Mr. Costa Saroukos was planned to come join this session. However, probably some of you may know this. In Japan, a couple of days ago in the weekend, so very strong typhoon came. And due to that, so traffic was damaged significantly, so unfortunately, CFO, Mr. Costa, cannot join today. So from IR team, Nobi-san joined us.
So this is a good opportunity for talking about R&D. And in November, you plan to have an R&D Day, annual R&D Day and it's the first R&D Day after the integration. So I'd like to ask you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
